Literature DB >> 11025720

Resolution of urge symptoms following sling cystourethropexy.

C G Schrepferman1, T L Griebling, I E Nygaard, K J Kreder.   

Abstract

PURPOSE: Persistence of urinary urge symptoms in women after pubovaginal sling cystourethropexy is a distressing problem. We assess the ability of preoperative video urodynamics to identify patients in whom urinary urge symptoms failed to resolve postoperatively.
MATERIALS AND METHODS: The records of 84 consecutive women who had undergone pubovaginal sling cystourethropexy were reviewed. Preoperative video urodynamics revealed stress urinary incontinence in all cases and concomitant detrusor instability in some. Cases of motor urge, defined as urge symptoms plus detrusor instability, were divided into low and high pressure categories. Patients with urge symptoms but no demonstrable detrusor instability on video urodynamics were diagnosed with sensory urge. Postoperatively complete urge resolution was defined as total absence of symptoms without pharmacological therapy. Mean followup was 26.7 months (range 2 to 62).
RESULTS: Of the 84 patients 41 with motor urge and 28 with sensory urge had preoperative urge symptoms. Complete resolution or improvement in urge symptoms occurred in 24 (58.5%) and 7 (17.1%) of the motor urge, and 11 (39.3%) and 9 (32.1%) of sensory urge cases, respectively. Of the 41 patients with motor urge 23 had low pressure instability, which completely resolved in 21 (91.3%) and improved in 2 (8.7%). Of the 18 remaining patients with high pressure motor urge only 5 (27. 8%) had complete resolution of urge and 5 (27.8%) had improvement.
CONCLUSIONS: Our results suggest that patients with low pressure motor urge are significantly more likely to experience resolution of urinary urge symptoms after pubovaginal sling cystourethropexy than those with high pressure motor urge or sensory urge.

Entities:  

Mesh:

Year:  2000        PMID: 11025720

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  Transobturator crossover readjustable sling for severe female incontinence: technique and preliminary results.

Authors:  Paulo Palma; Cassio Riccetto; Viviane Herrmann; Miriam Dambros; Rogério Fraga; Omar Grossi
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-02-15

2.  Prevalence of urinary urgency symptoms decreases by mid-urethral sling procedures for treatment of stress incontinence.

Authors:  Kirsi Palva; Carl Gustaf Nilsson
Journal:  Int Urogynecol J       Date:  2011-08-18       Impact factor: 2.894

Review 3.  Overactive bladder and mixed incontinence.

Authors:  Sunshine Murray; Gary E Lemack
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

4.  Expectations of stress urinary incontinence surgery in patients with mixed urinary incontinence.

Authors:  Benjamin M Brucker
Journal:  Rev Urol       Date:  2015

5.  Overactive bladder after sling surgery.

Authors:  Kamran P Sajadi; Sandip P Vasavada
Journal:  Curr Urol Rep       Date:  2010-11       Impact factor: 3.092

6.  Predictors of postoperative antimuscarinics in women with mixed urinary incontinence after transobturator surgery.

Authors:  Eun-Hee Yoo; Donguk Kim
Journal:  Int Urogynecol J       Date:  2012-07-14       Impact factor: 2.894

Review 7.  Mixed incontinence: stressing about urge.

Authors:  Jennifer Tash Anger; Larissa V Rodríguez
Journal:  Curr Urol Rep       Date:  2004-12       Impact factor: 3.092

Review 8.  The impact of detrusor overactivity on the management of stress urinary incontinence in women.

Authors:  H Henry Lai; Michael Simon; Timothy B Boone
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

9.  Mixed Incontinence: How Best to Manage It?

Authors:  Massimo Porena; Elisabetta Costantini; Massimo Lazzeri
Journal:  Curr Bladder Dysfunct Rep       Date:  2013-01-11

Review 10.  Treatment of mixed urinary incontinence.

Authors:  Alex Gomelsky; Roger R Dmochowski
Journal:  Cent European J Urol       Date:  2011-09-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.